Three-Statement Breakdown
REVENUE UP
Revenue rose 2.5% year over year to $14.5B, and carried a 22.2% net margin.
REVENUE
+2.5%
14,512
GROSS PROFIT
—
—
NET INCOME
+3.9%
3,223
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,681 | 14,540 | 14,282 | 14,155 | 14,123 | 14,092 | 14,151 | 14,512 | +2.6% | +2.5% | |
| Operating income |
RESTATED · WAS 5,262
10-Q
|
5,454 | 5,245 | 4,949 | 4,784 | 4,517 | 4,521 | 4,733 | 4,956 | +4.7% | +3.6% |
| Interest expense |
NOT DISCLOSED
10-Q
|
— | (832) | (831) | (834) | (838) | (844) | (848) | (847) | -0.1% | +1.6% |
| Income tax |
RESTATED · WAS (1,089)
10-Q
|
(1,144) | (1,085) | (1,009) | (969) | (883) | (880) | (924) | (978) | +5.8% | +0.9% |
| Net income |
RESTATED · WAS 3,483
10-Q
|
3,619 | 3,470 | 3,236 | 3,102 | 2,902 | 2,889 | 3,050 | 3,223 | +5.7% | +3.9% |
| EPS (diluted) | $1.85 | — | — | — | — | — | — | — | — | — | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-22 ↗